Status:
COMPLETED
Eye Movement Tracking to Detect Impairment Due to Acute Cannabis Intoxication
Lead Sponsor:
Oculogica, Inc.
Conditions:
Impairment
Cannabis Intoxication
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine the accuracy of an impairment algorithm based on eye tracking while watching a short film clip, in comparison to a clinical reference standard of impairment.
Eligibility Criteria
Inclusion
- Provide written informed consent.
- Have the ability to provide a complete ophthalmologic, medical and neurologic history as well as report medications/drugs/alcohol consumed within the 24 hours prior to tracking.
- Be at least 18 years old.
Exclusion
- Be blind (no light perception), have missing or non-functional eyes.
- Be unable to open their eyes.
- Have a history of unresolved strabismus, diplopia, amblyopia.
- Have a history of unresolved cranial nerve III, IV, or VI palsy.
- Have a history of unresolved macular edema, retinal degeneration, extensive cataract, or ocular globe disruption.
- Have a history of extensive prior eye surgery (examples include strabismus surgery, scleral buckle repair of retinal detachment, repair of blow out fractures of the orbit and any procedures that would interfere with extraocular muscle movements; prior cataract surgery or Lasik are not exclusions) or scarring.
- Have a prior history of unresolved ocular-motor dysfunctions.
- Have used cannabis, alcohol etc. 24 hours before study commences.
- Be 100% naïve to cannabis usage.
- Be pregnant.
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 7 2021
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT04799093
Start Date
February 1 2021
End Date
September 7 2021
Last Update
September 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Integrated Medicine LLC
Westport, Connecticut, United States, 06880